Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) are entero-pancreatic hormone-based treatments first approved in 2005 for type 2 diabetes (T2D). They are now commonly prescribed for weight ...

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...

Hims & Hers shares tanked after regulators signaled new limits on the production of versions of weight-loss drugs.

Can a popular medication used to change your body also be affecting your mood? It’s a question that some users of semaglutide ...

Now, providers and employers are also dealing with GI side effects from popular GLP-1 medications, which are used to treat type 2 diabetes and weight loss. While these drugs have helped millions ...

"There is a clear association between the use of GLPs and increased risks of food retention during upper endoscopy," Mathur ...

with type 2 diabetes, obesity, and stage 3 or 4 chronic kidney disease. Among the study participants, 183 patients underwent ...